文献速递肺栓塞与肺血管病间质性肺疾病

TBX4综合征首个基因型-表型研究:功能获得性突变可致肺病

First Genotype-Phenotype Study in TBX4 Syndrome: Gain-of-Function Mutations Causative for Lung Disease.
PubMed 文献 · Am J Respir Crit Care Med · 2022-01-01

该研究汇集137例携带TBX4单等位基因变异的患者,用新型荧光素酶报告系统评估42个错义变异的致病性,并与BMPR2突变组(162例)及无已知突变组(741例)比较。研究发现TBX4错义变异可呈功能获得性效应,且与较晚诊断年龄相关;位于T-BOX和核定位结构域的变异与更早发病及间质性肺病发生率增加相关。

要点

  • TBX4综合征不严格由单倍剂量不足所致,功能获得性突变也可致病。
  • T-BOX及核定位域变异与更早发病和间质性肺病风险增加相关。
  • TBX4变异携带者较BMPR2突变及无突变组诊断更年轻、基线肺功能更差。

核心结论

  • TBX4综合征可由功能获得性突变引起,并非仅由单倍剂量不足导致。
  • 致病突变所在蛋白结构域不同可部分解释TBX4在肺病中的多效性。

研究设计与样本

  • 多中心队列纳入137例携带TBX4单等位基因变异的患者。
  • 采用含T-BOX结合基序的新型荧光素酶报告系统评估42个错义变异的致病性。
  • 与BMPR2因果变异组(n=162)及PAH相关基因未识别变异组(n=741)进行基因型-表型比较分析。

主要发现

  • 功能评估发现TBX4错义变异存在功能获得性效应,与功能丧失性效应相比,与较晚的诊断年龄相关(P=0.038)。
  • 位于T-BOX和核定位结构域的变异与更早发病相关(P=0.005),并与间质性肺病发生率增加相关(P=0.003)。
  • T-BOX组无事件生存(死亡或移植)更短(P=0.022),但年龄在风险模型中亦有显著影响(P=0.0461)。
  • 与BMPR2组及未识别因果变异组相比,TBX4变异携带者诊断年龄更小(P<0.001),基线肺功能(FEV1、FVC)更差(P=0.009)。

关键数值与推荐

  • 功能获得性效应与较晚诊断年龄相关(P=0.038)。
  • T-BOX和核定位域变异与更早发病(P=0.005)及间质性肺病发生率增加(P=0.003)相关。
  • T-BOX组无事件生存更短(P=0.022),年龄在风险模型中显著(P=0.0461)。
  • TBX4变异携带者较BMPR2及无因果变异组诊断更年轻(P<0.001)、基线FEV1和FVC更差(P=0.009)。

临床怎么用

  • 对TBX4变异携带者应结合突变功能效应和蛋白结构域位置评估肺病风险与发病年龄。
  • TBX4变异携带者需关注间质性肺病可能,并评估基线肺功能。
  • T-BOX或核定位域变异患者可能发病更早、预后更差,需更密切随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Despite the increased recognition of TBX4 (T-BOX transcription factor 4)-associated pulmonary arterial hypertension (PAH), genotype-phenotype associations are lacking and may provide important insights. Objectives: To compile and functionally characterize all TBX4 variants reported to date and undertake a comprehensive genotype-phenotype analysis. Methods: We assembled a multicenter cohort of 137 patients harboring monoallelic TBX4 variants and assessed the pathogenicity of missense variation (n = 42) using a novel luciferase reporter assay containing T-BOX binding motifs. We sought genotype-phenotype correlations and undertook a comparative analysis with patients with PAH with BMPR2 (Bone Morphogenetic Protein Receptor type 2) causal variants (n = 162) or no identified variants in PAH-associated genes (n = 741) genotyped via the National Institute for Health Research BioResource-Rare Diseases. Measurements and Main Results: Functional assessment of TBX4 missense variants led to the novel finding of gain-of-function effects associated with older age at diagnosis of lung disease compared with loss-of-function effects (P = 0.038). Variants located in the T-BOX and nuclear localization domains were associated with earlier presentation (P = 0.005) and increased incidence of interstitial lung disease (P = 0.003). Event-free survival (death or transplantation) was shorter in the T-BOX group (P = 0.022), although age had a significant effect in the hazard model (P = 0.0461). Carriers of TBX4 variants were diagnosed at a younger age (P < 0.001) and had worse baseline lung function (FEV1, FVC) (P = 0.009) than the BMPR2 and no identified causal variant groups. Conclusions: We demonstrated that TBX4 syndrome is not strictly the result of haploinsufficiency but can also be caused by gain of function. The pleiotropic effects of TBX4 in lung disease may be in part explained by the differential effect of pathogenic mutations located in critical protein domains.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Prapa M, Lago-Docampo M, Swietlik EM, et al. First Genotype-Phenotype Study in TBX4 Syndrome: Gain-of-Function Mutations Causative for Lung Disease. Am J Respir Crit Care Med. 2022. PMID: 35852389. doi:10.1164/rccm.202203-0485OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。